220 related articles for article (PubMed ID: 17408737)
1. Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma.
Dass CR; Contreras KG; Dunstan DE; Choong PF
Biomaterials; 2007 Jul; 28(19):3026-33. PubMed ID: 17408737
[TBL] [Abstract][Full Text] [Related]
2. Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis.
Ek ET; Dass CR; Contreras KG; Choong PF
Cancer Gene Ther; 2007 Jul; 14(7):616-26. PubMed ID: 17479108
[TBL] [Abstract][Full Text] [Related]
3. PEDF-derived synthetic peptides exhibit antitumor activity in an orthotopic model of human osteosarcoma.
Ek ET; Dass CR; Contreras KG; Choong PF
J Orthop Res; 2007 Dec; 25(12):1671-80. PubMed ID: 17600821
[TBL] [Abstract][Full Text] [Related]
4. A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy.
Ta HT; Dass CR; Larson I; Choong PF; Dunstan DE
Biomaterials; 2009 Sep; 30(27):4815-23. PubMed ID: 19505719
[TBL] [Abstract][Full Text] [Related]
5. Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice.
Gao Y; Yao A; Zhang W; Lu S; Yu Y; Deng L; Yin A; Xia Y; Sun B; Wang X
Oncogene; 2010 May; 29(19):2784-94. PubMed ID: 20190814
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the collagen I-binding motif in the anti-angiogenic activity of pigment epithelium-derived factor.
Hosomichi J; Yasui N; Koide T; Soma K; Morita I
Biochem Biophys Res Commun; 2005 Sep; 335(3):756-61. PubMed ID: 16102727
[TBL] [Abstract][Full Text] [Related]
7. PEDF: a potential molecular therapeutic target with multiple anti-cancer activities.
Ek ET; Dass CR; Choong PF
Trends Mol Med; 2006 Oct; 12(10):497-502. PubMed ID: 16962374
[TBL] [Abstract][Full Text] [Related]
8. [Pigment epithelium-derived factor gene therapy inhibits the growth of transplanted human hepatocellular carcinoma in nude mice].
GAO Y; ZHANG W; ZHAO L; WANG XH
Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):363-7. PubMed ID: 19497203
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of PEDF expression by ribozyme transgene in endothelial and lung cancer cells and its impact on angiogenesis in vitro.
Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
Oncol Rep; 2005 Dec; 14(6):1615-9. PubMed ID: 16273265
[TBL] [Abstract][Full Text] [Related]
10. Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice.
Hase R; Miyamoto M; Uehara H; Kadoya M; Ebihara Y; Murakami Y; Takahashi R; Mega S; Li L; Shichinohe T; Kawarada Y; Kondo S
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8737-44. PubMed ID: 16361561
[TBL] [Abstract][Full Text] [Related]
11. Anti-angiogenic therapy for osteosarcoma.
Quan GM; Choong PF
Cancer Metastasis Rev; 2006 Dec; 25(4):707-13. PubMed ID: 17160710
[TBL] [Abstract][Full Text] [Related]
12. Topical application of anti-angiogenic peptides based on pigment epithelium-derived factor can improve psoriasis.
Abe R; Yamagishi S; Fujita Y; Hoshina D; Sasaki M; Nakamura K; Matsui T; Shimizu T; Bucala R; Shimizu H
J Dermatol Sci; 2010 Mar; 57(3):183-91. PubMed ID: 20060688
[TBL] [Abstract][Full Text] [Related]
13. Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model.
Abramson LP; Stellmach V; Doll JA; Cornwell M; Arensman RM; Crawford SE
J Pediatr Surg; 2003 Mar; 38(3):336-42; discussion 336-42. PubMed ID: 12632345
[TBL] [Abstract][Full Text] [Related]
14. Phosphomimetic mutants of pigment epithelium-derived factor with enhanced anti-choroidal melanoma cell activity in vitro and in vivo.
Feng Y; Bao W; Luo Y; Tian L; Chen X; Yi M; Xiong H; Huang Q
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6793-802. PubMed ID: 22952124
[TBL] [Abstract][Full Text] [Related]
15. High efficiency non-viral transfection of retinal and iris pigment epithelial cells with pigment epithelium-derived factor.
Thumann G; Stöcker M; Maltusch C; Salz AK; Barth S; Walter P; Johnen S
Gene Ther; 2010 Feb; 17(2):181-9. PubMed ID: 19741732
[TBL] [Abstract][Full Text] [Related]
16. Pigment epithelium-derived factor upregulates collagen I and downregulates matrix metalloproteinase 2 in osteosarcoma cells, and colocalises to collagen I and heat shock protein 47 in fetal and adult bone.
Alcantara MB; Nemazannikova N; Elahy M; Dass CR
J Pharm Pharmacol; 2014 Nov; 66(11):1586-92. PubMed ID: 25175851
[TBL] [Abstract][Full Text] [Related]
17. Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model.
Broadhead ML; Dass CR; Choong PF
Br J Cancer; 2011 Nov; 105(10):1503-11. PubMed ID: 21979423
[TBL] [Abstract][Full Text] [Related]
18. [Effects of pigment epithelial derived factor gene on growth of lung cancer cell and neovascularization: experiments with lung cancer cells and chick embryos].
Chen JF; Zhao W; Zhang JZ; Jiang WG; Zhang LJ
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(7):485-90. PubMed ID: 19567100
[TBL] [Abstract][Full Text] [Related]
19. The performance of doxorubicin encapsulated in chitosan-dextran sulphate microparticles in an osteosarcoma model.
Tan ML; Friedhuber AM; Dunstan DE; Choong PF; Dass CR
Biomaterials; 2010 Jan; 31(3):541-51. PubMed ID: 19836833
[TBL] [Abstract][Full Text] [Related]
20. [Feasibility of chitosan as gene therapy vehicle].
Wan YY; Zhang X; He YJ; Jiang WQ
Ai Zheng; 2005 Nov; 24(11):1408-11. PubMed ID: 16552973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
